138 related articles for article (PubMed ID: 25743991)
1. [Interferon free recovery for almost all patients].
Einecke D
MMW Fortschr Med; 2015 Mar; 157(4):71. PubMed ID: 25743991
[No Abstract] [Full Text] [Related]
2. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.
Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848
[No Abstract] [Full Text] [Related]
3. Assessing a broader user base for new HCV drug.
Sekkides O
Lancet Infect Dis; 2015 Apr; 15(4):383. PubMed ID: 25809898
[No Abstract] [Full Text] [Related]
4. Therapy for hepatitis C--the costs of success.
Hoofnagle JH; Sherker AH
N Engl J Med; 2014 Apr; 370(16):1552-3. PubMed ID: 24725236
[No Abstract] [Full Text] [Related]
5. Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection.
Graf Einsiedel H; Christiansen H; Wiegand J
Pediatr Infect Dis J; 2016 Dec; 35(12):1373. PubMed ID: 27832030
[No Abstract] [Full Text] [Related]
6. Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.
Enomoto M; Tateishi C; Tsuruta D; Tamori A; Kawada N
Ann Intern Med; 2018 May; 168(9):678-680. PubMed ID: 29335738
[No Abstract] [Full Text] [Related]
7. [LDV/SOF successful in general practice test].
Bischoff M
MMW Fortschr Med; 2016 Jun; 158 Suppl 1():62. PubMed ID: 27259909
[No Abstract] [Full Text] [Related]
8. Shorter treatments for hepatitis C: another step forward?
Foster GR
Lancet; 2015 Mar; 385(9973):1054-5. PubMed ID: 25591504
[No Abstract] [Full Text] [Related]
9. New Indications for Harvoni.
Med Lett Drugs Ther; 2016 Jan; 58(1485):6. PubMed ID: 27099890
[No Abstract] [Full Text] [Related]
10. Four weeks of ledipasvir/sofosbuvir and ribavirin with or without pegylated interferon for chronic hepatitis C in non-cirrhotic people who inject drugs. A randomized trial.
Øvrehus ALH; Krarup H; Birkemose I; Holm DK; Mössner B; Ernst A; Christensen PB
J Hepatol; 2018 Apr; 68(4):840-842. PubMed ID: 29223370
[No Abstract] [Full Text] [Related]
11. Are we hopefully very close to the end of HCV?
Tahan V
Turk J Gastroenterol; 2014 Apr; 25(2):230-1. PubMed ID: 25003693
[No Abstract] [Full Text] [Related]
12. Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy.
Bruzzone B; Magnani O; Sticchi L; Canepa P; Rappazzo E; Icardi G; Setti M
J Antimicrob Chemother; 2017 Oct; 72(10):2955-2958. PubMed ID: 29091216
[No Abstract] [Full Text] [Related]
13. Hepatitis C Virus and Schizophrenia: Expanding the Role of the Community Psychiatrist.
Herold S; Freudenreich O
Psychosomatics; 2016; 57(6):634-637. PubMed ID: 27418108
[No Abstract] [Full Text] [Related]
14. Anti-HCV for porphyria cutanea tarda.
Abdelmaksoud A
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133909
[No Abstract] [Full Text] [Related]
15. [Sofosbuvir/ledipasvir is also effective in routine general practice].
Warpakowski A
MMW Fortschr Med; 2016 Apr; 158 Spec No 1():65. PubMed ID: 27090681
[No Abstract] [Full Text] [Related]
16. Sovaldi dilemma likely to get worse.
Carroll J
Manag Care; 2014 Sep; 23(9):9, 12. PubMed ID: 25282860
[No Abstract] [Full Text] [Related]
17. Drug-Drug Interactions in Patients Co-infected With HCV and HIV.
Nozaki Y; Yanase M; Masaki N
JAMA; 2015 Jul; 314(2):186. PubMed ID: 26172899
[No Abstract] [Full Text] [Related]
18. Drug-Drug Interactions in Patients Co-infected With HCV and HIV--Reply.
Osinusi A; Townsend K; Kottilil S
JAMA; 2015 Jul; 314(2):186-7. PubMed ID: 26172900
[No Abstract] [Full Text] [Related]
19. Harvoni (ledipasvir and sofosbuvir) for hepatitis C.
Mullins C; Gibson W; Klibanov OM
Nurse Pract; 2015 Nov; 40(11):22-6. PubMed ID: 26474199
[No Abstract] [Full Text] [Related]
20. [Naturopathy consultation. Soon all patients will be curable. Decisive breakthrough in therapy of hepatitis C ].
Einecke D
MMW Fortschr Med; 2014 Feb; 156(3):26-7. PubMed ID: 24938054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
